Pharmacists’ perspectives on school stock inhaler access for children

Kalia Anderson, Lynn B. Gerald, Elizabeth Hall-Lipsy, Kathryn McCulley, Elizabeth Vuong, Hanna Phan

Research output: Contribution to journalArticlepeer-review


Several states in the United States (U.S.) have laws permitting stock inhalers, including short-acting beta-agonist inhalers, such as albuterol, and spacers to be prescribed to, dispensed to, and stocked in schools for use in students in respiratory distress, based on a protocol. This survey study assessed Arizona pharmacists’ (1) levels of comfort for dispensing a short-acting beta-agonist inhaler to an individual child versus a stock inhaler to a school, and (2) awareness of the related Arizona state law. Researchers surveyed pharmacists licensed in Arizona who self-reported practicing in an outpatient pharmacy setting. Among 251 pharmacist participants, 62% practiced in a chain community pharmacy. About 80.8% felt comfortable filling a prescription for an albuterol inhaler in a pediatric patient case, whereas only 26.7% felt comfortable filling a prescription for albuterol inhalers to be used as stock inhalers for a given school. Among those who would not fill the stock inhaler prescription, only 5.5% reported awareness of the state law compared to 42.6% of those who would fill it (p < 0.0001). This survey identified a lack of pharmacist awareness of state laws pertaining to stock inhalers for schools.

Original languageEnglish (US)
Pages (from-to)464-476
Number of pages13
JournalJournal of Public Health Policy
Issue number3
StatePublished - Sep 2023


  • Asthma
  • Children
  • Community pharmacy
  • Law
  • School
  • Stock inhaler

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Pharmacists’ perspectives on school stock inhaler access for children'. Together they form a unique fingerprint.

Cite this